Johnson & Johnson is undergoing a transformation in its product portfolio. These three ETFs may be worth buying.
Stocks move higher on Tuesday morning as earnings winners DuPont and Alibaba outpace weaker reports from the likes of Lockheed Martin.
There are many moving parts to J&J's latest earnings.
Johnson & Johnson posted better-than-expected fourth-quarter 2016 earnings amid lower 2017 forecasts.